Navigation Links
Pelleve(TM) Wrinkle Treatment System Featured On 'Beauty Spaces' TV Show
Date:10/14/2009

htening procedures is that with Pelleve(TM), I can get a successful result every time," said Dr. Stampar. When asked what he'd like patients to know about the Pelleve(TM) Wrinkle Treatment System, Stampar replied, "Getting a Pelleve(TM) treatment turns back the clock on the aging process and may help slow the progression of facial wrinkles, folds and loose skin that can lead patients to seek surgery later."

"We're excited to bring the next generation of skin-tightening technology to a national audience," said Tom Harper, Executive Vice President of Global Marketing for Ellman International, which developed the Pelleve(TM) Wrinkle Treatment System. "The opportunity to be featured on We and TLC is a step forward for Pelleve(TM), as consumers have the chance to learn about the procedure and how it may help them achieve their aesthetic goals."

Pelleve(TM) was introduced to the U.S. market earlier this year through dermatologists, plastic surgeons, ENTs and other cosmetic surgery clinics.

To see Pelleve(TM) on "Beauty Spaces" via the web, visit www.designingspaces.tv.

For more information about Pelleve(TM) or to locate doctors trained in using the Pelleve(TM) Wrinkle Treatment System, visit www.pelleve.com or call 1-877-KNOW-PELLEVE.

About Ellman International

Established in 1959, Ellman International (Oceanside, New York) is a privately held manufacturer of medical devices used to perform a variety of aesthetic and surgical procedures. The company's products are based on patented and proprietary technologies utilizing high frequency radiowaves to perform precision electrosurgery and laser procedures in the medical, dental and veterinary specialties. For more information, please visit www.ellman.com

SOURCE Ellman International


'/>"/>
SOURCE Ellman International
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pelleve Receives FDA Clearance for the Treatment of Mild to Moderate Facial Wrinkles
2. Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration
3. Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
4. Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles
5. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies
6. Curemark Enrolls First Patients in Phase III Clinical Trials for Autism Treatment
7. Eastern Europes First Novalis Tx(TM) Radiosurgery Platform Begins Radiotherapy Treatments in Latvia using RapidArc(R) Technology
8. ZyStor Therapeutics, Inc. Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease
9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
10. Metabolic Solutions Development Company To Test Potential Treatment for Alzheimers
11. CSL Behring Announces FDA Approval of Berinert(R), First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema in U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... Calif. , July 14, 2014  Mallinckrodt plc (NYSE: ... QCOR ) today announced that the registration statement on ... ("SEC") by Mallinckrodt plc on May 16, 2014 and amended ... of Mallinckrodt and Questcor that also constitutes a prospectus of ... statement on Form S-4 is available on the SEC,s EDGAR ...
(Date:7/14/2014)... 2014 BioAdaptives, Inc. (OTCBB:BDPT) is pleased to ... the roles of President and CEO of the Company.  ... the company that licensed its formulation, intellectual properties, and ... "Mr. Gerald Epling , who ... a privately held entity to a public company, has ...
(Date:7/13/2014)... , July 13, 2014  Eli Lilly ... announced results from its non-clinical study in genetically ... version of the beta-amyloid antibody N3pG and beta-secretase ... therapy was more effective in removing clumps of ... that is thought to lead to Alzheimer,s disease ...
Breaking Medicine Technology:Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 2Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 3Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 4Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 5Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 6Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 7BioAdaptives Prepares for Next Step 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3
... Aug. 5, 2011 Varian Medical Systems, Inc. (NYSE: ... former CEO and member of the Board of Directors for ... of management in global medical device businesses, has been appointed ... Varian,s Board of Directors also increased its size from nine ...
... FOREST, Ill., Aug. 5, 2011 Hospira, Inc. (NYSE: ... today announced U.S. Food and Drug Administration (FDA) approval of ... presentations include 200 mg, 1 gm and 2 gm with ... sales of more than $750 million in 2010, led by ...
Cached Medicine Technology:Hospira Announces U.S. Approval of Solution Version of Gemcitabine Injection 2Hospira Announces U.S. Approval of Solution Version of Gemcitabine Injection 3
(Date:7/14/2014)... Sunrise, FL (PRWEB) July 14, 2014 ... announced the expansion of its Quality Control and Assurance ... Formulations has hired two additional, highly-qualified quality assurance (QA) ... superior product standards for which IQ Formulations has become ... and QC technicians bring decades of stellar experience and ...
(Date:7/14/2014)... 2014 Secure Decisions, a leading provider ... with the Software Assurance Marketplace (SWAMP) to build a ... that drives everyday life. , The SWAMP, implemented by ... the Morgridge Institute for Research, is funded by the ... security practices by building a free facility with a ...
(Date:7/14/2014)... HealthDay Reporter SUNDAY, July ... a faltering sense of smell might signal the early ... smell test could spot who needs more extensive screening ... ability to identify odors was associated with the loss ... "We,re trying to be able to diagnose Alzheimer,s ...
(Date:7/14/2014)... 14, 2014 Follow ... liquid chromatography or UPLC is a new ... chromatography that involves the use of extremely ... separate chromatographic compounds. This highly sensitive qualitative ... and analysis of chromatography samples. UPLC functions ...
(Date:7/14/2014)... Francisco, California (PRWEB) July 14, 2014 ... expected to reach USD 4,285.1 million by 2020 ... a new study by Grand View Research, Inc. ... computational biology for bioinformatics R&D programs designed for ... increasing number of clinical studies in pharmacogenomics and ...
Breaking Medicine News(10 mins):Health News:Leading Health Supplement Company IQ Formulations Expands Quality Control and Assurance Department 2Health News:Madison-based SWAMP, Secure Decisions partner to enhance software security 2Health News:Madison-based SWAMP, Secure Decisions partner to enhance software security 3Health News:Could a Simple Smell Test Help Spot Alzheimer's Early? 2Health News:Could a Simple Smell Test Help Spot Alzheimer's Early? 3Health News:Need for Faster Sample Analysis Drives Demand for UPLC, According to New Trend Report Published by Global Industry Analysts, Inc. 2Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 2Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 3Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 4Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 5Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 6
... 7- to ... 9-hour flights, HOBOKEN, N.J., Nov. ... Pycnogenol(R), pine bark,extract from the French maritime pine tree, reduces jetlag in ... scan and a,scoring system, showed Pycnogenol(R) lowered symptoms of jetlag such as,fatigue, ...
... N.J., Nov. 5 BD (Becton,Dickinson and Company) (NYSE: ... for the fourth fiscal quarter ended September 30, 2008,representing ... period. This,quarter,s growth rate reflects the favorable impact on ... to account for 5,percentage points of the increase in ...
... Simulation and Education Conference (I/ITSEC) has sold ... County Convention Center in Orlando. Occupying almost 200,000 ... modeling and simulation technology ever. The I/ITSEC ... 2008 at the Orange County Convention Center in ...
... qualified health insurance underwriters, much of the frustration associated with filling ... serve to not only comfort users, but expedite the entire process, ... ... CA (PRWEB) November 5, 2008 -- Internet based insurance agency, TheHealthQuote, ...
... review outlines potential pharmaceutical, dietary, surgical, and other ... among women in the United States, and examines ... risk reduction strategies for women at average risk ... factors. Among the recommendations: aside from following general ...
... six hours of,deliberation, a Broward County Jury awarded a ... secondhand exposure case. Lynda and Michael Daly,claimed that Mrs. ... asbestos-containing brakes manufactured by Ford Motor Co. and,Pneumo Abex. ... was diagnosed in,May of 2007 and has been a ...
Cached Medicine News:Health News:Study Shows Pine Bark Reduces Jetlag 2Health News:Study Shows Pine Bark Reduces Jetlag 3Health News:Study Shows Pine Bark Reduces Jetlag 4Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 2Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 3Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 4Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 5Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 6Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 7Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 8Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 9Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 10Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 11Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 12Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 13Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 14Health News:World's Largest Modeling and Simulation Exhibition Sells Out for '08 2Health News:World's Largest Modeling and Simulation Exhibition Sells Out for '08 3Health News:Customers Now Able to Receive Real Time, Online Assistance during Health Insurance Quote Process 2Health News:Customers Now Able to Receive Real Time, Online Assistance during Health Insurance Quote Process 3
For Canalicular Stenosis. Non-traumatic tip. Silicone tubing swaged into probe. Note: Tubing securely swaged into malleable stainless steel probes. Medical grade silicone. Box of 3, sterile....
For proper plug sizing....
Contour Design Eyelid Implants....
For Frontalis Suspension in patients with significant ptosis and poor levator function....
Medicine Products: